Latest news about Triveni Group
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
For **Triveni Bio**, a significant recent development is the raising of $115 million in Series B financing to expand its pipeline of therapeutics for immunological and inflammatory disorders. This funding will advance its lead candidate, TRIV-509, with an IND submission planned for Q1 2025, and support its bispecific program, TRIV-573[1][4]. For **Triveni Engineering & Industries**, the company reported a 7.1% increase in revenues from operations for the half-year ending September 30, 2024, with robust growth in power transmission and alcohol sales. However, it faced challenges in sugar and ethanol production and is awaiting favorable ethanol price revisions to proceed with distillery expansions[5].
Triveni Engineering & Industries reported a net loss of ₹192.0m for the second quarter of FY25, despite a 25% increase in revenue to ₹17.6b. The company is expanding its alcohol business, with a planned capacity enhancement of ₹20 crore, and is incorporating digitalization and AI to optimize operations[3][4][5].
Triveni Engineering & Industries reported a 7.1% increase in revenues for the half-year ending September 30, 2024, driven by a 30% rise in power transmission revenues and a 9% increase in alcohol sales. However, the company faced challenges in sugar and ethanol production and is awaiting favorable ethanol price revisions to proceed with distillery expansions[5].
Open job positions at Triveni Group
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

